Strasbourg, France, April 24, 2024, 5:45 p.m. CET - Transgene , a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined.
Transgene Announces Financial Calendar for 2024 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Leuven, BELGIUM, Boston, MA, US - 11 April 2022 - 7.00 AM CET - Oxurion NV(Euronext Brussels: OXUR), a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with a
Oxurion has successfully raised EUR >10 million from leading US and European healthcare investors in a private equity placement and Negma Group has converted 240 convertible bonds in Oxurion resulting